Results 361 to 370 of about 266,977 (390)

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Type-2 Angiotensin II Receptor

2020
openaire   +1 more source

Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor &kgr;B

HYPERTENSION, 2010
F. Rompe, M. Artuc, A. Hallberg, M. Alterman, K. Ströder, C. Thöne-Reineke, A. Reichenbach, Jens Schacherl, B. Dahlöf, M. Bader, N. Alenina, M. Schwaninger, T. Zuberbier, H. Funke-Kaiser, Cosima Schmidt, W. Schunck, T. Unger, U. Steckelings   +17 more
semanticscholar   +1 more source

Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studies

Pain, 2016
Maree T. Smith, P. Anand, A. Rice
semanticscholar   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

The angiotensin II type 2 receptor: an enigma with multiple variations.

American Journal of Physiology. Endocrinology and Metabolism, 2000
S. Gallinat, S. Busche, M. Raizada, C. Sumners   +3 more
semanticscholar   +1 more source

The Adrenomedullary Angiotensin II Type 2 Receptor

2014
R. Nostramo, A. Tillinger, J.M. Saavedra, L. Serova, R. Kvetnansky, E.L. Sabban   +5 more
openaire   +1 more source